Page History
Expression Constraint | INVALID Expression |
| |||
Precoordinated | Postcoordinated | ||
|
pharmaceutical / biologic product
|
has active
ingredient
= < 105590001
substance
111115
inert tablet
Footnote Macro |
---|
Concepts for which an identifier has not been assigned have been shown with an identifier of '111115'. |
373873005
pharmaceutical / biologic product
:
{127489000
has active ingredient
= 412031009
paracetamol or derivative
},
{127489000
has active ingredient
= 387494007
codeine
},
{127489000
has active ingredient
= 255641001
caffeine
},
{127489000
has active ingredient
= 44068004
doxylamine
}
|
|
| ||||||
| ||||||||
|
|
| ||||||
| ||||||||
< 373873005 |pharmaceutical / biologic product| |
437867004
chlorphenamine + dextromethorphan + paracetamol + pseudoephedrine
< 373873005
pharmaceutical / biologic product
:
[1..1] 127489000
has active ingredient
= < 105590001
substance
111115
inert tablet
16
373873005
pharmaceutical / biologic product
:
{127489000
has active ingredient
= 412031009
paracetamol or derivative
},
{127489000
has active ingredient
= 387494007
codeine
}
412556009
paracetamol + codeine
< 373873005
pharmaceutical / biologic product
: [0..1] 127489000 |
|has active ingredient |
|= < 105590001 |
|substance| | 412556009 |
|paracetamol + codeine| | 373873005 |
|pharmaceutical / biologic product |
|: {127489000 |
|has active ingredient |
|= 412031009 |
|paracetamol or derivative |
|}, {127489000 |
|has active ingredient |
|= 387494007 |
|codeine |
|} |
< 373873005 |
|pharmaceutical / biologic product |
|: [1..*] 127489000 |
|has active ingredient |
|= < 105590001 |
|substance| | 111115 |
|inert tablet |
|18 | 373873005 |
|pharmaceutical / biologic product |
|: 411116001 |
|has dose form |
|= 385055001 |
|tablet| |
< 404684003 |
|clinical finding |
|: [1..1] 363698007 |
|finding site |
|= |
< 91723000 |
|anatomical structure| | 75857000 |
|fracture of radius and ulna| | 404684003 |
|clinical finding |
|: {116676008 |
|associated morphology |
|= 72704001 |
|fracture |
|, 363698007 |
|finding site |
|= 62413002 |
|bone structure of radius |
|, 363698007 |
|finding site |
|= 23416004 |
|bone structure of ulna |
|} |
40733004 |
|infectious disease |
| |
< 404684003 |
|clinical finding |
|: [2..*] 363698007 |
|finding site |
|= |
< 91723000 |
|anatomical structure| | 23406007 |
|arm fracture| | 404684003 |
|clinical finding |
|: {116676008 |
|associated morphology |
|= 72704001 |
|fracture |
|, 363698007 |
|finding site |
|= 702468001 |
|bone structure of lower leg |
|} |
40733004 |
|infectious disease| |
< 404684003 |
|clinical finding |
|: { [2..*] 363698007 |
|finding site |
|= < 91723000 |
|anatomical structure |
|} | 75857000 |
|fracture of radius and ulna| | 64572001 |
|disease |
| : {116676008 |
|associated morphology |
|= 396351009 |
|congenital septal defect |
|, 363698007 |
|finding site |
|= 113262008 |
|thoracic aorta structure |
| } {116676008 |
|associated morphology |
|= 90141005 |
|congenital hypertrophy |
| , 363698007 |
|finding site |
|= 244384009 |
|entire right ventricle |
|} |
< 373873005 |
|pharmaceutical / biologic product |
|: [1..3] { [1..*] 127489000 |
|has active ingredient |
|= < 105590001 |
|substance |
|} | 111115 |
|inert tablet |
Footnote Macro |
---|
Concepts for which an identifier has not been assigned have been shown with an identifier of '111115'. |
373873005
|[2] | 373873005 |pharmaceutical / biologic product |
|: {127489000 |
|has active ingredient |
|= 412031009 |
|paracetamol or derivative |
|}, {127489000 |
|has active ingredient |
|= 387494007 |
|codeine |
|}, {127489000 |
|has active ingredient |
|= 255641001 |
|caffeine |
|}, {127489000 |
|has active ingredient |
|= 44068004 |
|doxylamine |
|} |
437867004 |
|chlorphenamine + dextromethorphan + paracetamol + pseudoephedrine| |
< 373873005 |
|pharmaceutical / biologic product |
|: [0..1] { 127489000 |
|has active ingredient |
|= < 105590001 |
|substance |
| } | 412556009 |
|paracetamol + codeine| | 373873005 |
|pharmaceutical / biologic product |
|: {127489000 |
|has active ingredient |
|= 412031009 |
|paracetamol or derivative |
|}, {127489000 |
|has active ingredient |
|= 387494007 |
|codeine |
|} |
< 373873005 |
|pharmaceutical / biologic product |
|: [1..*] { 127489000 |
|has active ingredient |
|= < 105590001 |
|substance |
| } | 111115 |
|inert tablet |
|19 | 373873005 |
|pharmaceutical / biologic product |
|: 411116001 |
|has dose form |
|= 385055001 |
|tablet| |
< 404684003 |
|clinical finding |
|: [1..1] { 363698007 |
|finding site |
|= |
< 91723000 |
|anatomical structure |
|} | 75857000 |
|fracture of radius and ulna| | 404684003 |
|clinical finding |
|: {116676008 |
|associated morphology |
|= 72704001 |
|fracture |
|, 363698007 |
|finding site |
|= 62413002 |
|bone structure of radius |
|, 363698007 |
|finding site |
|= 23416004 |
|bone structure of ulna |
|} |
40733004 |
|infectious disease |
| |
< 404684003 |
|clinical finding |
|: [0..0] { [2..*] 363698007 |
|finding site |
|= < 91723000 |
|anatomical structure |
|} | - | 64572001 |
|disease |
| : {116676008 |
|associated morphology |
|= 396351009 |
|congenital septal defect |
|, 363698007 |
|finding site |
|= 25943004 |
|structure of atrioventricular node |
|, 363698007 |
|finding site |
|= 113262008 |
|thoracic aorta structure |
| } {116676008 |
|associated morphology |
|= 90141005 |
|congenital hypertrophy |
| , 363698007 |
|finding site |
|= 244384009 |
|entire right ventricle |
|} |
...
Display Footnotes Macro |
---|